A Randomized, Double-Blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata

    Shahla Mirzaeei, Ashkan Barfar, Saba Mehrandish, Ali Ebrahimi
    TLDR The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.
    The study evaluated the efficacy and safety of a 2% minoxidil nanosuspension with an aqueous base for treating androgenetic alopecia areata in 70 patients over six months. Results indicated no significant difference in efficacy between the nanosuspension and the commercial product, but the nanosuspension demonstrated better safety and tolerability, suggesting it as a suitable alternative with enhanced patient compliance.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    2 / 2 results